Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:36 UTC |
---|
HMDB ID | HMDB0014407 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Carmustine |
---|
Description | Carmustine, also known as BCNU or gliadel, belongs to the class of organic compounds known as nitrosoureas. Nitrosoureas are compounds containing a nitro group and an urea group N-N linked together, with the general structure R1N(R2)C(=O)N(R3)N=O. Carmustine is a drug which is used for the treatment of brain tumors, multiple myeloma, hodgkin's disease and non-hodgkin's lymphomas. Carmustine (bis-chloroethylnitrosourea, BCNU, BiCNU) is a medication used mainly for chemotherapy. Carmustine is an extremely weak basic (essentially neutral) compound (based on its pKa). Outside of the human body, Carmustine has been detected, but not quantified in, mollusks. This could make carmustine a potential biomarker for the consumption of these foods. It is also used as part of a chemotherapeutic protocol in preparation for hematological stem cell transplantation, a type of bone marrow transplant, in order to reduce the white blood cell count in the recipient. Carmustine is formally rated as a probable carcinogen (by IARC 2A) and is also a potentially toxic compound. It is a nitrogen mustard β-chloro-nitrosourea compound. In the treatment of brain tumours, the U.S. Food and Drug Administration (FDA) approved biodegradable discs infused with carmustine (Gliadel). . The product is now available as a generic version with other manufacturers offering the product licensed in the USA and EU markets. Carmustine is used as an alkylating agent to treat several types of brain cancer including glioma, glioblastoma multiforme, medulloblastoma and astrocytoma), multiple myeloma, and lymphoma (Hodgkin's and non-Hodgkin). They are implanted under the skull during a surgery called a craniotomy. In India it is sold under various brand names, including Consium. |
---|
Structure | InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11) |
---|
Synonyms | Value | Source |
---|
BCNU | ChEBI | Bicnu | ChEBI | Bischloroethyl nitrosourea | ChEBI | Carmustina | ChEBI | Carmustinum | ChEBI | Gliadel | ChEBI | N,N'-bis(2-chloroethyl)-N-nitrosourea | ChEBI | Bischlorethylnitrosourea | HMDB | Bischlorethylnitrosurea | HMDB | Carmustin | HMDB | FIVB | HMDB | Nitrumon | HMDB | 1,3-Bis(2-chloroethyl)-1-nitrosourea | HMDB |
|
---|
Chemical Formula | C5H9Cl2N3O2 |
---|
Average Molecular Weight | 214.05 |
---|
Monoisotopic Molecular Weight | 213.007181961 |
---|
IUPAC Name | 1,3-bis(2-chloroethyl)-3-nitrosourea |
---|
Traditional Name | carmustine |
---|
CAS Registry Number | 154-93-8 |
---|
SMILES | ClCCNC(=O)N(CCCl)N=O |
---|
InChI Identifier | InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11) |
---|
InChI Key | DLGOEMSEDOSKAD-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as nitrosoureas. Nitrosoureas are compounds containing a nitro group and an urea group N-N linked together, with the general structure R1N(R2)C(=O)N(R3)N=O. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Organic carbonic acids and derivatives |
---|
Sub Class | Ureas |
---|
Direct Parent | Nitrosoureas |
---|
Alternative Parents | |
---|
Substituents | - Nitrosourea
- Semicarbazide
- Nitrosamide
- Organic n-nitroso compound
- Organic nitroso compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Alkyl chloride
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Carbonyl group
- Alkyl halide
- Organic nitrogen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 31 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 1.53 g/L | Not Available | LogP | 1.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Carmustine,1TMS,isomer #1 | C[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 1737.4 | Semi standard non polar | 33892256 | Carmustine,1TMS,isomer #1 | C[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 1684.0 | Standard non polar | 33892256 | Carmustine,1TMS,isomer #1 | C[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 2692.9 | Standard polar | 33892256 | Carmustine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 1937.9 | Semi standard non polar | 33892256 | Carmustine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 1911.2 | Standard non polar | 33892256 | Carmustine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCl)C(=O)N(CCCl)N=O | 2710.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Carmustine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0bu0-6900000000-7ee333c26479b9275253 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carmustine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Carmustine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 10V, Positive-QTOF | splash10-06vi-9630000000-1b262631b4a720cd9eba | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 20V, Positive-QTOF | splash10-0a6r-9500000000-fbebb9877cfb22d2c3d8 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 40V, Positive-QTOF | splash10-03fr-9000000000-86de321ebee3984d7705 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 10V, Negative-QTOF | splash10-116u-4930000000-a2c48761c56e3640e06b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 20V, Negative-QTOF | splash10-004l-6900000000-fc62a96dc02889b5a3b7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 40V, Negative-QTOF | splash10-004l-9200000000-d116bdf5580083ca15c7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 10V, Positive-QTOF | splash10-03di-4390000000-26b54291487efd0acb6f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 20V, Positive-QTOF | splash10-03di-9400000000-52b9e7457ec89c9907c2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 40V, Positive-QTOF | splash10-03di-9000000000-d239cf72a61995f936f3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 10V, Negative-QTOF | splash10-03di-4390000000-a11de64a3d45d4733ab2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 20V, Negative-QTOF | splash10-001i-9200000000-a9b03f4595d1bb5cb7d2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Carmustine 40V, Negative-QTOF | splash10-001i-9200000000-14857476fd37bc517cbb | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|